Dietary protein absorption in neonatal mammals and fishes relies on the function of a specialized and conserved population of highly absorptive lysosome-rich enterocytes (LREs). The gut microbiome has been shown to enhance absorption of nutrients, such as lipids, by intestinal epithelial cells. However, whether protein absorption is also affected by the gut microbiome is poorly understood.
View Article and Find Full Text PDFAntimicrobial peptides (AMPs) are attractive candidates to combat antibiotic resistance for their capability to target biomembranes and restrict a wide range of pathogens. It is a daunting challenge to discover novel AMPs due to their sparse distributions in a vast peptide universe, especially for peptides that demonstrate potencies for both bacterial membranes and viral envelopes. Here, we establish a de novo AMP design framework by bridging a deep generative module and a graph-encoding activity regressor.
View Article and Find Full Text PDFACS Appl Mater Interfaces
March 2025
This study successfully synthesized microporous nitrogen-doped biomass porous carbon (NPSCs) through a two-step method, utilizing cost-effective peanut shells as the carbon source, urea as the nitrogen source, and CHCOOK as the activating agent. By optimizing the ratio of the activating agent and the carbonization temperature, the pore structure and surface chemical properties of the NPSCs were effectively tailored. Characterization results revealed that the NPSCs exhibited a significant number of micropores, attributed to the critical etching effect of CHCOOK.
View Article and Find Full Text PDFBackground: The systemic inflammation response index (SIRI) as an immune marker, is associated with prognosis of urological malignancies(UM). However, the conclusion remains controversial. Therefore, the objective of this study was to conduct a meta-analysis to comprehensively evaluate the predictive value of SIRI in patients with UM.
View Article and Find Full Text PDFAutologous stem cell transplantation (ASCT) and chimeric antigen receptor T-cells (CAR-T) have been used as consolidation therapies for patients with refractory/relapsed B cell non-Hodgkin's lymphoma (R/R B-NHL) in remission after second-line chemotherapy or salvage therapy. However, patients with different pathological subtypes and remission states may benefit differently from ASCT or CAR-T cell therapy. Furthermore, consolidation treatment involving ASCT or CAR-T cells still poses a significant risk of disease relapse.
View Article and Find Full Text PDF